MedPath

Comparison of treatment with Repetitive Trans cranial Magnetic Stimulation with medication, with medication alone in obsessive-compulsive disordered

Phase 3
Recruiting
Conditions
Obsessive compulsive disorder resistance to drug therapy.
Obsessive-compulsive disorder
Registration Number
IRCT20190622043979N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Age 18-60
A previous history of OCD for at least one year, treated with the first two Obsessive drugs approved by the FDA, has not been improved and is right-handed.
In the YBOCS questionnaire, the score was more than or equal to 16, and in the Beck questionnaire the score was not higher than 17.

Exclusion Criteria

Accompanied with other psychiatric disorders
History of seizure or epileptic seizures
Beck questionnaire score above 17
Pregnancy
Substance abuse based on biographie
History of severe head trauma or severe neurological complications
Metal implant or pace maker

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement. Timepoint: Obsessive compulsive disorder will be assessed in both groups of A and B after 3 weeks. Method of measurement: At the end of the study, the mean scores of the questionnaire, as well as the clinical observations and clinical assessments of the questioner, were compared in both groups compared to the beginning of the study and the other group in order to determine the effectiveness of each regimen independently and in comparison with others as well as the rate of remission.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath